Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
SPRO
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w high -13.4%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
spero
therapeutics
nasdaq
multi
2023
2024
inducement
announced
clinical
drug
bacterial
infections
stage
focused
today
results
biopharmaceutical
cambridge
mass
globe
SPRO
Spero Therapeutics, Inc. Common Stock
Stonvex